News and Announcements
Wholesale Investor Worldwide Tour Recap
- Published November 13, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
19 days, 7 Cities, 6 Countries, 7 Showcase Events, 2 WI Private Cocktail Functions & 800 Attendees!
Written by Steve Torso, Wholesale Investor, Managing Director
The last 3 weeks have been the most ambitious mission we have ever embarked on.
Are we insane? Maybe! However, this is what drives us! Every day for us is about creating an opportunity for tomorrow. Our mission is to provide the platform for Emerging Companies to create trade and investment opportunities in new markets. It is a simple case of “you never know unless you try”.
In attendance we had Ultra High Net Worth Investors, Sovereign Funds, Individual and Multi-Family Offices, Fund Managers, Venture Capital and Private Equity firms, and the list goes on. It still fascinates me, that we have this level of money profile attending our events across so many countries.
Within the Wholesale Investor subscriber base, is a unique ecosystem. It is one that is constantly evolving, changing and growing.
What is beautiful about it, is that one conversation, one introduction or one registration of interest can change the entire destiny of a company and the people behind. The challenge is, you never know when, where or with whom that interaction will be.
- The companies which joined us for the journey
- The Australian High Commissioner to Singapore, Bruce Gosper and the Singapore Austrade team
- The Investors who engaged with our clients
- Our Shareholders. Thank you to the Investec and BMY Group teams for supporting our mission
- The Wholesale Investor team. There is a significant addition of pressure when you deliver events across multiple countries
- Shareinvestor, The Investor and KOTRA.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
